What's New

Last Posted: Dec 23, 2020

• Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the RAD51C Gene.
  Sanoguera-Miralles Lara et al. Cancers 2020 Dec 12(12)
• The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences
  JW Pan et al, Nat Comms, December 22, 2020
• A Breast Radiology Department-operated, Proactive Same-day Program Identifies Pathogenic Breast Cancer Mutations in Unaffected Women.
  Loving Vilert A et al. Academic radiology 2020 Dec
• Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma.
  Jing Na et al. Annals of translational medicine 2020 Nov 8(21) 1447
• Germline TP53 Testing in Breast Cancers: Why, When and How?
  Evans D Gareth et al. Cancers 2020 Dec 12(12)
• Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients.
  Assi Hazem I et al. Journal of oncology 2020 20209238084
• Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis.
  Yumiceba Verónica et al. Frontiers in endocrinology 2020 11585130
• Artificial intelligence (AI) in breast cancer care - Leveraging multidisciplinary skills to improve care.
  Cardoso Maria Joao et al. Breast (Edinburgh, Scotland) 2020 Dec
• A Collaborative Effort to Define Classification Criteria for ATM Variants in Hereditary Cancer Patients.
  Feliubadaló Lidia et al. Clinical chemistry 2020 Dec
• Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer.
  Sparano Joseph A et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Dec JCO2003007
• Polygenic Risk Scores for Genetic Counseling in Psychiatry: Lessons Learned from other Fields of Medicine.
  Eeltink E et al. Neuroscience and biobehavioral reviews 2020 Dec
• The run-in phase of the prospective WSG-ADAPT HR+/HER2- trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.
  Nitz Ulrike et al. Therapeutic advances in medical oncology 2020 121758835920973130
• A 'Real-Life' Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer.
  Braun Marcin et al. Diagnostics (Basel, Switzerland) 2020 Dec 10(12)
• Heritability of Low ER Staining/HER2-Breast Tumors: Are We Missing an Opportunity for Germline Testing?
  Lovejoy Leann A et al. Genes 2020 Dec 11(12)
• The Utility of Deep Learning in Breast Ultrasonic Imaging: A Review.
  Fujioka Tomoyuki et al. Diagnostics (Basel, Switzerland) 2020 Dec 10(12)